A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

Clinical trial NCT01621204 · COMPLETED

Trial details

NCT number: NCT01621204
Sponsor: McMaster University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2012-10-01
Primary completion: 2019-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.